Goodbye, Dolly?

SciAm has an article and excerpts of an interview with Ian Wilmut, the first person to use somatic cell nuclear transfer to clone a mammal. Wilmut has almost entirely switched his research focus to creating iPS cells because, like many others, he sees that weeding through the ethical and technical issues around SCNT just isn't worth it.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A research duo estimates in PLOS One the number of papers that have used misidentified cell lines.

UK's National Institute for Health and Care Excellence approves GlaxoSmithKline's SCID gene therapy despite cost.

Science reports that Brazilian researchers are petitioning for the reversal of budget cuts.

In PLOS this week: gene flow patterns in common ash, guidelines for using morpholinos in zebrafish, and more.